Agios Pharmaceuticals, Inc. (AGIO)
32.60
-0.49
(-1.48%)
USD |
NASDAQ |
Aug 24, 16:00
32.33
-0.27
(-0.83%)
After-Hours: 19:58
Agios Pharmaceuticals Debt to Equity Ratio : 0.0304 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0304 |
| March 31, 2026 | 0.0322 |
| December 31, 2025 | 0.0337 |
| September 30, 2025 | 0.0347 |
| June 30, 2025 | 0.0356 |
| March 31, 2025 | 0.0361 |
| December 31, 2024 | 0.037 |
| September 30, 2024 | 0.0374 |
| June 30, 2024 | 0.0978 |
| March 31, 2024 | 0.0919 |
| December 31, 2023 | 0.0888 |
| September 30, 2023 | 0.0851 |
| June 30, 2023 | 0.0819 |
| March 31, 2023 | 0.0794 |
| December 31, 2022 | 0.0778 |
| September 30, 2022 | 0.0847 |
| June 30, 2022 | 0.0811 |
| March 31, 2022 | 0.0784 |
| December 31, 2021 | 0.0752 |
| September 30, 2021 | 0.0711 |
| June 30, 2021 | 0.0592 |
| March 31, 2021 | 0.0451 |
| December 31, 2020 | 0.2633 |
| September 30, 2020 | 0.2233 |
| June 30, 2020 | 0.1958 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1781 |
| December 31, 2019 | 0.1775 |
| September 30, 2019 | 0.2574 |
| June 30, 2019 | 0.2187 |
| March 31, 2019 | 0.1211 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Biogen, Inc. | 0.4433 |
| Insmed, Inc. | 0.9865 |
| Liquidia Corp. | 0.9374 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.108B |
| Total Liabilities (Quarterly) | 82.40M |
| Shareholders Equity (Quarterly) | 1.026B |
| Current Ratio | 10.22 |
| Net Debt Paydown Yield | 0.20% |